Zepbound 5 MG/0.5 ML pen 0.5ML
Ended Awarded Last action
- Contract number
- SPE2DR26FCZ9W
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $57,975
Award facts
- Contract value 100% obligated
- $57,975.30 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $57,975.30 delivery order to AmerisourceBergen Drug Corp (UEI: KABZK8W6PQT3) on January 15, 2026, for the supply of Zepbound 5 mg/0.5 mL pens, a GLP-1 receptor agonist medication used for weight management. This firm fixed-price delivery order, which is expected to be completed by January 16, 2026, was issued under a non-competitive set-aside and will be fulfilled at the contractor's facility in Conshohocken, Pennsylvania. The awardee is a subsidiary of Cencora, Inc. (formerly AmerisourceBergen), a major pharmaceutical distributor serving federal government healthcare systems.
This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. This comprehensive pharmaceutical supply vehicle enables the contractor to deliver a broad range of medications, vaccines, and medical supplies to support military healthcare programs worldwide, including the Defense Health Agency, U.S. Coast Guard, and other federal medical institutions. The parent company, Cencora, Inc., also holds a separate $999,999,999.00 IDC with DLA Troop Support Medical extending through December 2031, further demonstrating the company's critical role in the federal pharmaceutical supply chain.
Quick answers
Who was awarded contract SPE2DR26FCZ9W?
SPE2DR26FCZ9W was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 15, 2026.
How much is contract SPE2DR26FCZ9W worth?
The government has obligated $57,975 on SPE2DR26FCZ9W.
Is contract SPE2DR26FCZ9W an order under another contract?
Yes. SPE2DR26FCZ9W is a delivery order under SPE2DR25D1100, an indefinite delivery contract.
Was contract SPE2DR26FCZ9W competed?
The extent of competition for SPE2DR26FCZ9W was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award